Atlas Trials

Metastatic HER2+ Advanced Breast Cancer

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic HER2+ Advanced Breast Cancer

RecordFirmDate
Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer. (NCT06961331)Pfizer2025-05-07
Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) (NCT05382364)Pfizer2022-06-29

Track Metastatic HER2+ Advanced Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.